Navigation Links
Novel surgery removes rare tumor, rebuilds trachea
Date:1/28/2011

DETROIT Using a novel surgical approach, it's possible to rebuild the trachea and preserve a patient's voice after removing an invasive throat tumor, according to a new report from Henry Ford Hospital in Detroit.

This case study is the first of its kind to not only document a successful technique to create a fully functional trachea, or windpipe, but also report a rare type of malignant tumor in an adult's trachea. Most commonly, this type of tumor is seen in newborns and very rarely occurs in the neck, says lead study author Samer Al-Khudari, M.D., with the Department of Otolaryngology-Head & Neck Surgery at Henry Ford Hospital.

"In this case, the patient's tumor had spread to the trachea, thyroid gland, muscles around the thyroid gland and nerves in the area," says Dr. Al-Khudari.

According to head and neck cancer surgeon Tamer A. Ghanem, M.D., Ph.D., who led the Henry Ford surgical team, the easiest approach would have been to remove the trachea and the voice box, given the tumor's proximity to the larynx and other surrounding structures. With this method, however, the patient would no longer be able to speak or swallow normally.

Instead, the surgical team took another approach. Using tissue and bone from the patient's arm, they were able to reconstruct the trachea, restoring airflow through the trachea and saving the patient's voice.

"We had to think outside the box to not only safely remove the tumor, but to allow for optimum functional outcome," says Dr. Ghanem, director of the Head and Neck Oncology & Microvascular Surgery Division at Henry Ford. "This is the first time such a large portion of a patient's trachea has been removed and rebuilt in a way that allows it to be fully functional."

This unique case will be presented Jan. 29 at the poster session for the Triological Society's Combined Section Meeting in Scottsdale, Ariz.

The case study is centered on a 27 year-old man who had a large mass blocking 90 percent of his airway, making it very difficult for him to breathe.

After a biopsy and other tests, Henry Ford doctors determined the mass was a malignant immature teratoma a cancerous tumor that was quickly spreading throughout the areas of the patient's trachea and surrounding structures.

Such tumors are extremely rare; since the first reported case in 1854, there have only been 300 other reported cases.

With the Henry Ford patient, surgeons first removed the tumor and about half of the patient's airway, just below the voice box.

Using bone and skin from the patient's arm and two titanium plates, surgeon's reconstructed the airway, providing it with full coverage and allowing it to be fully functional.

Reconstruction of the trachea is challenging, due to the structural complexity and unique properties of the airway. The ideal reconstruction must not collapse during respiration and have some degree of mobility to allow for neck movement.

Currently the patient is using a tracheostomy tube a tube that is inserted into an opening in the trachea to assist with breathing but the surgeons do not expect it to be permanent. The patient, however, is able to speak and swallow normally. He also underwent chemotherapy as part of his treatment.


'/>"/>

Contact: Krista Hopson
khopson1@hfhs.org
313-874-7207
Henry Ford Health System
Source:Eurekalert

Related medicine news :

1. Researchers reveal function of novel molecule that underlies human deafness
2. Novel therapy for metastatic kidney cancer developed at VCU Massey Cancer Center
3. UCI researchers find novel memory-enhancing mechanism in brain
4. Novel imaging technique may reduce lymphedema in breast cancer patients
5. New standards of care and novel treatment options for several forms of lymphoma unveiled
6. Novel genetic mutation that causes the most common form of eye cancer discovered
7. Quebec City researchers pave the way for novel treatment of pulmonary hypertension
8. Eat safer: Novel approach detects unknown food pathogens
9. Novel Drug Eases Osteoarthritis Knee Pain
10. Novel biomarker may predict response to new VEGF receptor inhibitor
11. Novel Rheumatoid Arthritis Drug Shows Early Promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... 2017 , ... The Asset Tracking and Temperature monitoring system works in conjunction ... the bar code of the product and lot ID then scanning the HPP basket ... are automatically generated and exception alerts sent out to designated individuals. , "In recognizing ...
(Date:9/25/2017)... ... September 25, 2017 , ... Leonard Bley, MD ... next generation for LASIK in Manhattan with Contoura Vision, the latest WaveLight® topographic-guided ... systems available in the United States to correct nearsightedness and nearsightedness with astigmatism. ...
(Date:9/25/2017)... ... , ... “Renew Refresh Restore Reward”: is a story of struggle and how ... published author, Deborah Freeman, cofounded the Free Spirit Bible Church and currently serves as ... my sister-in-law invited us to come over before the baby had to go back ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... “The Majestic ... unicorns—during the great flood. “The Majestic Unicorn” is the creation of published author, Dayna ... or small, came from far and wide to march aboard the cypress ark-vessel. Male ...
(Date:9/25/2017)... Los Angeles, CA (PRWEB) , ... September 25, 2017 , ... ... opening of a full-time office in downtown Los Angeles, to service existing clients in ... the surrounding areas. , “We are seeing an ever-increasing amount of business demand west ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... --  PDI , a leader in infection prevention products ... session focused on the role of chlorhexidine gluconate (CHG) ... 2017 Annual Scientific Meeting of the Association for Vascular ... Phoenix Convention Center in ... also feature PDI,s Prevantics® Device Swab as ...
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
Breaking Medicine Technology: